Zobrazeno 1 - 10
of 53
pro vyhledávání: '"J. M. Brinkman"'
Autor:
M. H. van Haeringen, P. P. F. M. Kuijer, J. G. Daams, R. C. I. van Geenen, J. M. Brinkman, G. M. M. J. Kerkhoffs, R. J. van Heerwaarden, A. Hoorntje
Publikováno v:
Knee Surgery, Sports Traumatology, Arthroscopy.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Journal of Thrombosis and Haemostasis, 11(6), 1111-1118. Wiley
Summary Background Rivaroxaban has been approved as an antithrombotic agent for prevention of venous thromboembolism with specific indications. At present no antidote is appointed and no guidelines have been formulated for the measurement of Rivaroxa
Autor:
P. G. De Groot, Jan Voorberg, Mariëtte Boon-Spijker, Koen Mertens, I. Dienava-Verdoold, B. de Laat, R. H. W. M. Derksen, H.-J. M. Brinkman
Publikováno v:
Journal of thrombosis and haemostasis, 9(4), 738-747. Wiley-Blackwell
Journal of Thrombosis and Haemostasis, 9(4), 738-747. Wiley
Journal of Thrombosis and Haemostasis, 9(4), 738-747. Wiley
Patients with antiphospholipid syndrome (APS) display a heterogeneous population of antibodies with beta(2) glycoprotein-1 (?(2)GP1) as the major antigen.We isolated and characterized human mAbs directed against ?(2)GP1 from the immune repertoire of
Publikováno v:
British Journal of Sports Medicine. 40:966-969
Objective: To determine the clinical outcome of arthroscopic debridement for osteochondritis dissecans of the elbow. Methods: A prospective cohort study was started in 2000; between 2000 and 2005, 15 patients (six male, nine female, mean age 28 years
Autor:
Sabina Kersting, H.-J. M. Brinkman, Rob Fijnheer, Thalia Romani de Wit, Jan A. van Mourik, Ronald J. Hené
Publikováno v:
British Journal of Haematology. 123:522-527
Summary. It is generally assumed that endothelial cell injury is the primary event in the pathogenesis of thrombotic thrombocytopenic purpura (TTP). In this study, we have determined the extent of vascular perturbation during acute episodes of the di
Publikováno v:
Arteriosclerosis, Thrombosis, and Vascular Biology. 22:511-516
Apparently quiescent, nonapoptotic endothelial cells mediate the activation of factor X by activated factor IX in the presence of its cofactor, activated factor VIII. In a previous study, we reported that during the activation of factor X, the intera
Autor:
Koen Mertens, Alexander B. Meijer, I. Dienava-Verdoold, H.-J. M. Brinkman, Mariëtte Boon-Spijker, Fabian Stavenuiter
Publikováno v:
Journal of thrombosis and haemostasis : JTH. 10(5)
Summary. Background: Factor seven activating protease (FSAP) was initially reported as an activator of single-chain urokinase-type plasminogen activator (scuPA) and factor VII (FVII). Subsequently, numerous additional substrates have been identified,
Autor:
Koen Mertens, K. Grijm, L. Zwart-Huinink, H.-J. M. Brinkman, Joost C. M. Holthuis, J. A. Van Mourik
Publikováno v:
British Journal of Haematology. 87:332-342
Rates of factor X activation on endothelial cells were compared with activation rates on other vascular cells, platelets, monocytes and negatively charged phospholipid vesicles. Factor VIIa-mediated factor X activation was observed on smooth muscle c